Pinosol spray naz. fl. 10ml

Release form, composition and packaging

?

Nasal drops in the form of a clear liquid from blue to green-blue in color, with a menthol-eucalyptus smell.

10 g (1 fl.)

Scots pine oil 375.2 mg

eucalyptus oil 50 mg

thymol 3.2 mg

α-tocopherol acetate 170 mg

peppermint oil 100 mg

guayazulene 2 mg

butylhydroxyanisole - 1.2 mg, esters of macrogol and glycerides of apricot oil (labrafil M-1944-CS) - 1 g, vegetable oil - 8.2985 g. 10 ml - brown glass bottles with a rubber pipette with a lid (1) - cardboard packs.

pharmachologic effect

Herbal decongestant.

It has anti-inflammatory and antiseptic properties.

Pharmacokinetics

Data on the pharmacokinetics of Pinosol® are not available.

Indications for use

- acute rhinitis

- chronic atrophic rhinitis

- acute and chronic inflammatory diseases of the mucous membranes of the nose and nasopharynx, accompanied by dryness of the mucous membranes of the nose

- conditions after surgery in the nasal cavity - as prescribed by a doctor (in a hospital and outpatient setting).

Contraindications for use

- allergic rhinitis

- children under 2 years old

- hypersensitivity to drug components.

Dosage regimen

For adults, on the 1st day, the drug is instilled in 1-2 drops into each nasal passage with an interval of 1-2 hours. In the following days - 1-2 drops in each nasal passage 3-4 times / day.

Children are instilled 1-2 drops 3-4 times / day or use a cotton swab.

It is possible to use the drug in the form of inhalation, which should be carried out using an inhaler.

For this, 2 ml (50 drops) is instilled into the inhaler

frequency of application - 2-3 times / day.

The duration of treatment is 5-7 days.

Overdose

Until now, there have been no cases of overdose of Pinosol®.

Side effect

Local reactions: itching, burning sensation, hyperemia and swelling of the nasal mucosa.

Drug interactions

The drug interaction of the drug Pinosol® is not described.

Application during pregnancy and lactation

It is possible to use the drug Pinosol® during pregnancy and lactation (breastfeeding) according to indications.

Special instructions In the event of adverse events or other unusual reactions not described in the instructions, the patient should consult a doctor.

Name ENG

PINOSOL

Clinical and pharmacological group

Antimicrobial and anti-inflammatory drug for topical use in ENT practice

ATX code

Decongestants and other topical preparations

Dosage

etc.

x 10ml

Structure

10 ml contains: Active ingredients: mountain pine oil 350 mg, peppermint oil 100 mg, eucalyptus oil 50 mg, alpha-tocopherol acetate 150 mg, thymol 3 mg

Excipients: medium chain triglycerides.

Indications

acute and chronic rhinitis of non-allergic etiology

rhinopharyngitis

infectious and inflammatory diseases of the mucous membrane of the nose and nasopharynx.

Storage conditions and periods

In a dark place at a temperature of 15-25 degrees.

Expiration date: 2 years

Contraindications

allergic rhinitis

children under 3 years old

hypersensitivity to drug components.

INN / Active ingredient

alpha-tocopherol acetate, guaiazulene, thymol, eucalyptus oil, peppermint oil, pine oil

Specifications

Category

Runny nose

Scope of the drug

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Ukraine

Package quantity, pcs

one

Scope of application

Virology

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Zentiva

The amount of the dosage form in the primary package

10 ml

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal decongestant

Dosage form

Nasal spray

Expiration date in days

730

Package weight, g

ten

Mode of application

:

Pinosol spray is injected in 1 dose into each nasal passage 3-6 times a day, depending on the severity of the inflammatory process.

The course of treatment is 10 days.

An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.

Primary packaging type

:

Light-protective glass bottle with dosing pump and nasal adapter

Anatomical and therapeutic characteristics

:

R01AX30 Topical nasal preparations in combination